EKF Diagnostics Holdings Plc Cash Flow Conversion Efficiency
EKF Diagnostics Holdings Plc cash flow conversion efficiency. Based on the latest financial reports, EKF Diagnostics Holdings Plc (EKF) has a cash flow conversion efficiency ratio of 0.046x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX3.32 Million ≈ $403.70 USD) by net assets (GBX71.58 Million ≈ $8.71K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of EKF Diagnostics Holdings Plc (2001–2025)
Cash flow conversion efficiency of EKF Diagnostics Holdings Plc from 2001 to 2025. This chart illustrates how EKF Diagnostics Holdings Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View EKF stock price and chart for real-time trading data and today's change.
EKF Diagnostics Holdings Plc Cash Flow Conversion Ratio Explained
EKF Diagnostics Holdings Plc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
EKF Diagnostics Holdings Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EKF Diagnostics Holdings Plc ranked by their cash flow conversion efficiency. Also see EKF company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SIG plc
LSE:SHI
|
0.208x |
|
Bkm Industries Limited
NSE:BKMINDST
|
-1.155x |
|
Sileon AB
ST:SILEON
|
-0.285x |
|
Urban-Gro Inc
NASDAQ:UGRO
|
0.056x |
|
Dixie Gold Inc
V:DG
|
-0.501x |
|
Virax Biolabs Group Limited Ordinary Shares
NASDAQ:VRAX
|
-0.576x |
|
Sono Group N.V.
NASDAQ:SSM
|
-2.078x |
|
Atomic Minerals Corp
V:ATOM
|
-0.496x |
Annual Cash Flow Conversion Efficiency for EKF Diagnostics Holdings Plc (2001–2025)
The table below shows the annual cash flow conversion efficiency of EKF Diagnostics Holdings Plc from 2001 to 2025. Review EKF free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX70.28 Million ≈ $8.55K |
GBX9.71 Million ≈ $1.18K |
0.138x | -25.95% |
| 2024-12-31 | GBX73.21 Million ≈ $8.91K |
GBX13.66 Million ≈ $1.66K |
0.187x | +101.62% |
| 2023-12-31 | GBX68.22 Million ≈ $8.30K |
GBX6.31 Million ≈ $767.87 |
0.093x | -28.84% |
| 2022-12-31 | GBX74.52 Million ≈ $9.07K |
GBX9.69 Million ≈ $1.18K |
0.130x | +20.30% |
| 2021-12-31 | GBX94.74 Million ≈ $11.53K |
GBX10.24 Million ≈ $1.25K |
0.108x | -38.80% |
| 2020-12-31 | GBX78.20 Million ≈ $9.51K |
GBX13.81 Million ≈ $1.68K |
0.177x | +146.43% |
| 2019-12-31 | GBX71.17 Million ≈ $8.66K |
GBX5.10 Million ≈ $620.52 |
0.072x | -44.98% |
| 2018-12-31 | GBX63.90 Million ≈ $7.78K |
GBX8.32 Million ≈ $1.01K |
0.130x | -12.96% |
| 2017-12-31 | GBX60.50 Million ≈ $7.36K |
GBX9.05 Million ≈ $1.10K |
0.150x | +2.02% |
| 2016-12-31 | GBX60.97 Million ≈ $7.42K |
GBX8.94 Million ≈ $1.09K |
0.147x | +260.04% |
| 2015-12-31 | GBX46.75 Million ≈ $5.69K |
GBX-4.29 Million ≈ $-521.36 |
-0.092x | -68.80% |
| 2014-12-31 | GBX87.38 Million ≈ $10.63K |
GBX-4.74 Million ≈ $-577.21 |
-0.054x | -210.70% |
| 2013-12-31 | GBX40.92 Million ≈ $4.98K |
GBX2.01 Million ≈ $244.19 |
0.049x | +20.93% |
| 2012-12-31 | GBX39.43 Million ≈ $4.80K |
GBX1.60 Million ≈ $194.55 |
0.041x | +288.32% |
| 2011-12-31 | GBX37.43 Million ≈ $4.55K |
GBX-806.00K ≈ $-98.07 |
-0.022x | +64.04% |
| 2010-12-31 | GBX23.53 Million ≈ $2.86K |
GBX-1.41 Million ≈ $-171.43 |
-0.060x | +50.22% |
| 2009-12-31 | GBX5.62 Million ≈ $683.79 |
GBX-676.00K ≈ $-82.25 |
-0.120x | +5.74% |
| 2008-12-31 | GBX5.07 Million ≈ $616.87 |
GBX-647.00K ≈ $-78.72 |
-0.128x | -210.05% |
| 2007-12-31 | GBX4.98 Million ≈ $605.44 |
GBX577.00K ≈ $70.20 |
0.116x | +160.35% |
| 2006-12-31 | GBX4.30 Million ≈ $523.06 |
GBX-826.00K ≈ $-100.50 |
-0.192x | -3668.00% |
| 2005-12-31 | GBX3.71 Million ≈ $451.89 |
GBX20.00K ≈ $2.43 |
0.005x | +101.97% |
| 2004-12-31 | GBX3.12 Million ≈ $379.01 |
GBX-852.00K ≈ $-103.66 |
-0.274x | -2390.00% |
| 2003-12-31 | GBX2.46 Million ≈ $299.07 |
GBX-27.00K ≈ $-3.29 |
-0.011x | -498.46% |
| 2002-12-31 | GBX2.90 Million ≈ $353.09 |
GBX8.00K ≈ $0.97 |
0.003x | -99.58% |
| 2001-12-31 | GBX214.00K ≈ $26.04 |
GBX142.00K ≈ $17.28 |
0.664x | -- |
About EKF Diagnostics Holdings Plc
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit rea… Read more